Online registration for this event is closed.
Please contact email@example.com or call
518-431-7846 if you have questions about the event.
Opioid use and OUD treatment during COVID-19 and beyond
Noon - 1 p.m.
This event is open to HANYS members and non-members.
This session will address current epidemiology, new legislation and innovative resources in supporting persons with opioid use disorder. Clinical responses and current trends in substance use and overdoses will be explored and various buprenorphine resources will be discussed in the context of COVID-19. The webinar also will highlight New York MATTERS updates.
- review new resources being developed to address opioid use/OUD;
- identify current trends in substance use and overdoses;
- describe buprenorphine resources and other low threshold resources in the context of COVID-19;
- review New York MATTERS updates; and
- present current epidemiological statistics and briefly discuss new legislation.
Kelly S. Ramsey, MD, MPH, MA, FACP, FASAM, Chief of Medical Services, Office of Addiction Services and Supports
Sharon Stancliff, MD, Associate Medical Director of Harm Reduction in Healthcare, New York State Department of Health Aids Institute
This webinar is part of HANYS’ Commitment to Excellence Emerging Quality Trends Series. Each session will cover a different cutting-edge topic to expand healthcare providers' clinical expertise and share proven best practices to deliver high-quality care. For more information about this program, contact Erin Gretzinger, CPHQ, director, Quality Advocacy, Research, and Innovation, at 518.431.7744 or firstname.lastname@example.org.
If you have questions regarding registration, please contact Registration Support at email@example.com or 518.431.7867.